Understanding And Ameliorating The Human Health Effects Of Exposure To Air Pollution: From Knowledge To Policy And Public Health Practice
Funder
National Health and Medical Research Council
Funding Amount
$2,584,848.00
Summary
Urban consolidation and sprawl, traffic congestion, mining, climate change, heating and cooling living environments, and power generation – these manifestations of modernity produce regular headlines. Air pollution and its effects on human health are the focus of much popular concern. This CRE will build an integrated research capacity in the field of air pollution and its effects on human health that will allow Australia to address these major challenges - now and in the future.
The COVID-19 pandemic has highlighted the risk of closed, indoor settings due to accumulation of aerosols generated from breathing, speaking, coughing or sneezing. Any airborne threat, whether an infectious virus or a chemical agent, will create a higher exposure in indoor settings. To mitigate this risk, using inter-disciplinary expertise, this research will improve preparedness, reduce health impacts of airborne threats, inform worker and occupant safety, building design and healthy futures.
Centre Of Research Excellence In The Early Prevention Of Obesity In Childhood
Funder
National Health and Medical Research Council
Funding Amount
$2,483,243.00
Summary
One in five Australian children are already overweight or obese at age 5 years, by the time of school entry. Early childhood is a period when physical inactivity and poor eating habits become established and may persist life-long. We propose a Centre of Research Excellence in the Early Prevention of Obesity in Childhood. The Centre aims to reduce the prevalence of obesity and obesity-related behaviours in the first five years of life, and their future impact.
Centre Of Research Excellence For The Study Of Naevi
Funder
National Health and Medical Research Council
Funding Amount
$2,496,835.00
Summary
Most melanomas grow adjacent to or within pre-existing benign neoplasms of the skin called naevi. Many studies have shown that the number of nevi on an individual predicts their risk of developing melanoma. New naevi form and existing ones change regularly in children and also adults. While previous work aimed to reduce the burden of melanoma has focussed on malignant tumours, much can be learned from increasing our understanding of tumorigenesis by studying benign tumours such as naevi.
Reducing Salt Intake Using Food Policy Interventions
Funder
National Health and Medical Research Council
Funding Amount
$2,491,067.00
Summary
Excess salt consumption has been identified as a leading cause of ill health and a priority area for action. Australia and most other countries around the world have signed up to the 30% reduction in mean population salt intake recommended by the World Health Organisation, but the strategies that will be used to achieve this goal remain to be decided. This Centre will address the design, implementation, evaluation and roll out of real-world food policy interventions targeting salt reduction.
Centre For Research Excellence In The Evaluation, Management And Health Care Needs Of Polycystic Ovary Syndrome And Related Health Implications
Funder
National Health and Medical Research Council
Funding Amount
$2,595,120.00
Summary
Polycystic Ovary Syndrome is a common condition with major health impacts, affecting one in five young Australian and one in four Indigenous women. This condition has reproductive, metabolic and emotional implications including obesity, infertility, diabetes and poor quality of life. This CRE will bring together a team of collaborative research and translation experts to improve diagnosis, capture vital prevention opportunities, optimise management and improve quality of life.
Centre Of Research Excellence: Partnering With Patients With Chronic Kidney Disease To Transform Care And Outcomes (CRE-PACT)
Funder
National Health and Medical Research Council
Funding Amount
$2,500,000.00
Summary
CRE-PACT will partner with patients to generate and translate new high-priority evidence to improve outcomes that are important to people living with chronic kidney disease (CKD). We will address the topics and questions most important to patients. We will build the next generation of research leaders and a community of research-ready patient-partners. There will be an integrated pathway for evidence translation and implementation at a global scale to improve patient-centred outcomes.
Chronic Kidney Disease Centre Of Research Excellence
Funder
National Health and Medical Research Council
Funding Amount
$2,606,487.00
Summary
The Chronic Kidney Disease Centre of Research Excellence (CKD.CRE) is an Australian first, dedicated to the improvement of CKD knowledge and management across the health care spectrum. With five research streams, the CKD.CRE will establish a national surveillance network, support improved detection in primary care, inform on renal supportive care and on rationalised resource utilisation. In addition, the CKD.CRE will conduct biomarker research and will establish Australia’s first CKD BioBank.
Centre Of Research Excellence In Disability And Health
Funder
National Health and Medical Research Council
Funding Amount
$2,487,345.00
Summary
The first research centre of its kind internationally, the CRE in Disability and Health brings together a first-rate team of national and international researchers with influential stakeholders. We will create the evidence needed to guide social and health policy reform with the explicit intent of improving the health of working age disabled Australians. We will produce an exceptional research workforce equipped to make large-scale, ongoing contributions to the field of disability and health.
Creating Sustainable Healthcare: Ensuring New Diagnostics Avoid Harms, Improve Outcomes, And Direct Resources Wisely
Funder
National Health and Medical Research Council
Funding Amount
$2,497,658.00
Summary
Novel imaging, biomarkers and genomic tests for risk assessment and early detection are emerging as major forces for change in clinical practice. While providing advances and new benefits for patients, new technologies can also have harmful, unintended consequences - overdiagnosis and overtreatment. This multidisciplinary CRE will investigate how to respond to emerging technologies to optimise health outcomes while avoiding harms and directing healthcare resources wisely.